.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Daiichi Sankyo
Healthtrust
US Army
Merck
Deloitte
UBS
Citi
Express Scripts
Cantor Fitzgerald

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206448

« Back to Dashboard

NDA 206448 describes NEVIRAPINE, which is a drug marketed by Aurobindo, Cipla Ltd, Alvogen Malta, Apotex Inc, Aurobindo Pharma Ltd, Macleods Pharms Ltd, Mylan Pharms Inc, Sandoz Inc, Tech Organized, Cipla, Hetero Labs Ltd Iii, Micro Labs Ltd, Mylan Labs, Prinston Inc, and Strides Pharma, and is included in twenty-two NDAs. It is available from seventeen suppliers. Additional details are available on the NEVIRAPINE profile page.

The generic ingredient in NEVIRAPINE is nevirapine. There are twenty drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the nevirapine profile page.

Summary for 206448

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 206448

Suppliers and Packaging for NDA: 206448

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NEVIRAPINE nevirapine TABLET, EXTENDED RELEASE;ORAL 206448 ANDA Cipla USA Inc. 69097-403 69097-403-11 480 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-403-11)
NEVIRAPINE nevirapine TABLET, EXTENDED RELEASE;ORAL 206448 ANDA Cipla USA Inc. 69097-403 69097-403-02 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-403-02)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength400MG
Approval Date:Oct 15, 2015TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Cerilliant
Argus Health
Dow
Johnson and Johnson
Fish and Richardson
Harvard Business School
Chinese Patent Office
Novartis
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot